NCT01637220View on ClinicalTrials.gov

Role of Neutrophil Activation in Anaphylaxis to Neuro-Muscular Blocking Agents

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

July 31, 2015

Study Completion Date

December 31, 2015

Conditions
Anaphylactic Shock to Neuro-Muscular Blocking Agents (NMBA)
Interventions
BIOLOGICAL

Blood volume collected specifically for this study

"* case patient: 10 ml after the anaphylactic reaction, and during the Allergology-Anesthesia consult 6 to 8 weeks after the shock le choc.~* Control patients: 20 ml following neuromuscular blocking drug injection"

Trial Locations (1)

75018

Hospital BICHAT, Paris

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT01637220 - Role of Neutrophil Activation in Anaphylaxis to Neuro-Muscular Blocking Agents | Biotech Hunter | Biotech Hunter